Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer

Abstract

Dynamic and quantitative analysis of EGFR mutation in ctDNA could guide personalized therapy for advanced ADC. NGS shows good performance in multiple genes testing especially novel and uncommon genes.